Evidence map›Paper›PMID 26452536›Full record

ArticleAnnals of the rheumatic diseases2016

Netrin-1 is highly expressed and required in inflammatory infiltrates in wear particle-induced osteolysis.

Aránzazu Mediero, Bhama Ramkhelawon, Tuere Wilder, P Edward Purdue, Steven R Goldring, M Zahidunnabi Dewan, Cynthia Loomis, Kathryn J Moore, Bruce N Cronstein

Abstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Targeting Unc5b in macrophages drives atherosclerosis regression and pro-resolving immune cell function.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Article
  8. Therapeutic effects of MSCs, genetically modified MSCs, and NFĸB-inhibitor on chronic inflammatory osteolysis in aged mice.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  9. Article
  10. Article
  11. Netrin-1: A Modulator of Macrophage Driven Acute and Chronic Inflammation.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Review
  14. Lack of Myosin X Enhances Osteoclastogenesis and Increases Cell Surface Unc5b in Osteoclast-Lineage Cells.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019
    Article
  15. Article
  16. Article
  17. Netrins & Semaphorins: Novel regulators of the immune response.Biochimica et biophysica acta. Molecular basis of disease · 2017
    Review
  18. Article
  19. Article
  20. Netrin-1 and its receptor Unc5b are novel targets for the treatment of inflammatory arthritis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Aránzazu MedieroDivision of Translational Medicine, Department of Medicine, NYU School of Medicine, New York, New York, USA.
Bhama RamkhelawonLeon H. Charney Division of Cardiology, Department of Medicine, NYU School of Medicine, New York, New York, USA.
Tuere WilderDivision of Translational Medicine, Department of Medicine, NYU School of Medicine, New York, New York, USA.
P Edward PurdueHospital for Special Surgery, New York, New York, USA.
Steven R GoldringHospital for Special Surgery, New York, New York, USA.
M Zahidunnabi DewanOffice of Collaborative Sciences, NYU School of Medicine, New York, New York, USA.
Cynthia LoomisOffice of Collaborative Sciences, NYU School of Medicine, New York, New York, USA Department of Pathology, NYU School of Medicine, New York, New York, USA.
Kathryn J MooreLeon H. Charney Division of Cardiology, Department of Medicine, NYU School of Medicine, New York, New York, USA.
Bruce N CronsteinDivision of Translational Medicine, Department of Medicine, NYU School of Medicine, New York, New York, USA.
New York University · USHospital for Special Surgery · US

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
Institutional Clinical and Translational Science AwardUL1TR000038 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2012 to 2014
$16.8M
TRABECULAR BONE ADAPTATION TO MECHANICAL LOADINGP30AR046121 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI DOTY, STEPHEN BRUCE · 1999 to 2010
$5.5M
The Pharmacology of Dermal Fibrosis R01AR056672 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2009 to 2018
$4.6M
Purinergic Stimulation of Bone RegenerationR01AR068593 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COELHO, PAULO G, CRONSTEIN, BRUCE NEIL · 2015 to 2019
$2.8M
Purinergic Regulation of Bone MetabolismR01AR054897 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2008 to 2014
$2.1M
Immunomodulatory functions of neuronal guidance cuesRC1HL100815 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MOORE, KATHRYN J · 2009 to 2010
$997k
The Pharmacology of Dermal FibrosisR56AR056672 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2014 to 2014
$373k
Dysregulation of Neuronal Guidance Cue Netrin-1 in Accelerated AAAK99HL125667 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RAMKHELAWON, BHAMA · 2015 to 2016
$221k
NCATS NIH HHS UL1 TR000038NCATS NIH HHS UL1 TR001445NCI NIH HHS P30 CA016087NHLBI NIH HHS K99 HL125667NHLBI NIH HHS RC1 HL100815NIAMS NIH HHS P30 AR046121NIAMS NIH HHS R01 AR054897NIAMS NIH HHS R01 AR056672NIAMS NIH HHS R01 AR068593NIAMS NIH HHS R56 AR056672
6 · The paper itself

Abstract

objectiveNetrin-1 is a chemorepulsant and matrix protein expressed during and required for osteoclast differentiation, which also plays a role in inflammation by preventing macrophage egress. Because wear particle-induced osteolysis requires osteoclast-mediated destruction of bone, we hypothesised that blockade of Netrin-1 or Unc5b, a receptor for Netrin-1, may diminish this pathological condition.

methodsC57BL/6 mice, 6-8 weeks old, had 3 mg of ultrahigh-molecular-weight polyethylene particles implanted over the calvaria and then received 10 µg of monoclonal antibodies for Netrin-1 or its receptors, Unc5b and deleted in colon cancer (DCC), injected intraperitoneally on a weekly basis. After 2 weeks, micro-computed tomography and histology analysis were performed. Netrin-1 expression was analysed in human tissue obtained following primary prosthesis implantation or after prosthesis revision for peri-implant osteolysis and aseptic implant loosening.

resultsWeekly injection of anti-Netrin-1 or anti-Unc5b-antibodies significantly reduced particle-induced bone pitting in calvaria exposed to wear particles (46±4% and 49±3% of control bone pitting, respectively, p<0.001) but anti-DCC antibody did not affect inflammatory osteolysis (80±7% of control bone pitting, p=ns). Anti-Netrin-1 or anti-Unc5b, but not anti-DCC, antibody treatment markedly reduced the inflammatory infiltrate and the number of tartrate resistance acid phosphatase (TRAP)-positive osteoclasts (7±1, 4±1 and 14±1 cells/high power field (hpf), respectively, vs 12±1 cells/hpf for control, p<0.001), with no significant changes in alkaline phosphatase-positive osteoblasts on bone-forming surfaces in any antibody-treated group. Netrin-1 immunostaining colocalised with CD68 staining for macrophages. The peri-implant tissues of patients undergoing prosthesis revision surgery showed an increase in Netrin-1 expression, whereas there was little Netrin-1 expression in soft tissues removed at the time of primary joint replacement.

conclusionsThese results demonstrate a unique role for Netrin-1 in osteoclast biology and inflammation and may be a novel target for prevention/treatment of inflammatory osteolysis.

Indexed as

AnimalsBone and BonesInflammationMaleMiceMice, Inbred C57BLNerve Growth FactorsNetrin-1Netrin ReceptorsOsteoclastsOsteolysisPolyethylenesReceptors, Cell SurfaceSkullTumor Suppressor ProteinsNerve Growth FactorsNetrin-1Netrin ReceptorsNTN1 protein, humanNtn1 protein, mousePolyethylenesReceptors, Cell SurfaceTumor Suppressor Proteinsultra-high molecular weight polyethyleneBone Mineral DensityInflammationTreatment

Identifiers

PMID26452536
PMCPMC5349296
OpenAlexW2227442317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.